The Journal of Community and Supportive OncologyOmacetaxine for chronic or accelerated phase CML in patients with resistance or intolerance to TKIsSeptember 3, 2013Leukemia, Myelodysplasia, TransplantationPractice ManagementCMLBusiness of Medicine
Oncology PracticeSplenectomy mortality risk similar for malignant and benign diseaseAugust 8, 2013GastroenterologyLeukemia, Myelodysplasia, TransplantationGastrointestinal Cancer
Oncology PracticeNew biomarker predicts treatment-resistant GVHD August 7, 2013Leukemia, Myelodysplasia, Transplantation
Oncology PracticeRevised IPSS bests other systems for predicting MDS outcomesAugust 6, 2013Leukemia, Myelodysplasia, Transplantation
Oncology PracticeVTE rate triples in pediatric cancer survivorsJuly 12, 2013PediatricsLeukemia, Myelodysplasia, TransplantationPatient & Survivor Care
Oncology PracticeCD123 differentiates acute GVHD from infections, drug reactionsJuly 12, 2013GastroenterologyLeukemia, Myelodysplasia, TransplantationGastrointestinal Cancer
Oncology PracticeObinutuzumab plus chlorambucil packs 1-2 punch against CLL in elderlyJuly 2, 2013Leukemia, Myelodysplasia, Transplantation
The Journal of Community and Supportive OncologyEnsuring optimal adherence to BCR-ABL1 tyrosine kinase inhibitor therapy for chronic myeloid leukemiaJuly 2, 2013Leukemia, Myelodysplasia, Transplantation
Oncology PracticeSimple conditioning, GVHD prophylaxis yields good hematologic malignancy survivalJune 24, 2013Leukemia, Myelodysplasia, TransplantationRare Diseases
Oncology PracticeIdelalisib and rituximab produce responses in 97% with CLLJune 11, 2013Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hospital Physician: Hematology/OncologyPost-transplant Lymphoproliferative DisordersJune 1, 2013Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
The Journal of Community and Supportive OncologyBosutinib in previously treated CML and in first-line comparison with imatinibMay 29, 2013Leukemia, Myelodysplasia, Transplantation
Oncology PracticeOral idelalisib elicits response in half of refractory CLL patientsMay 16, 2013Leukemia, Myelodysplasia, Transplantation
Oncology PracticeGene finding may permit targeted therapy for neutrophilic leukemiaMay 8, 2013Leukemia, Myelodysplasia, Transplantation
Oncology PracticeGenetic profiles more clearly defined in endometrial cancer, AMLMay 2, 2013Gynecologic CancerLeukemia, Myelodysplasia, Transplantation
